Industry: Pharmaceuticals, Biotechnology
Adenosine Therapeutics focuses on the discovery and development of novel pharmaceutical products that selectively target the four known adenosine receptor subtypes. Candidates for drug development are identified and screened using the company’s state-of-the-art adenosine receptor screening platform technology. The company was founded with the goal of taking new adenosine-receptor selective drugs into clinical trials for a broad range of potential indications. These drug indications include inflammatory indications, sepsis, heart attack, ischemia-reperfusion injury, vascular injury, spinal cord injury, COPD, asthma, diabetes, obesity, inflammatory bowel disease, retinopathy, and Parkinson’s disease. The company’s most advanced drug development program is in Phase III clinical development. ( www.adenrx.com )
Adenosine Therapeutics , LLC
P.O. Box 4632
Charlottesville, Virginia 22905
USA
Tel: (434) 220-9400
Fax: (434) 971-6912